McAdam LLC
WST icon

McAdam LLC’s West Pharmaceutical WST Stock Holding History

McAdam LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$201K Buy
+542
New +$191K 0.01% 501

Other funds holding WST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

McAdam LLC's WST Position: Q3 2026 in Review

McAdam LLC opened a new position in West Pharmaceutical (WST) in Q3 2026: 542 shares worth $201K. The stake represents 0.01% of the portfolio and ranks #501 among its holdings.

515 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • McAdam LLC held 542 shares of West Pharmaceutical worth $201K as of Q3 2026.
  • West Pharmaceutical was a new McAdam LLC position in Q3 2026.
  • West Pharmaceutical made up 0.01% of McAdam LLC's portfolio in Q3 2026, its #501 holding.
  • 515 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on McAdam LLC's 13F filing for Q3 2026, filed 21 Oct 2026.